Validity and Reliability Study of the Pain Indicator Behavior Scale-Brain Damage (ESCID-DC)

NCT ID: NCT04898491

Last Updated: 2025-04-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-01

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A multicentre observational study to validate the adaptation of the Pain Indicator Behavior Scale (ESCID) for patients with acquired Brain Damage (ESCID-DC), as a measuring instrument.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Non-commercial study. The study complies with the ethical principles of the Declaration of Helsinki, the recommendations of Good Clinical Practice (GCP) and current legislation.

The study has been approved with a favorable opinion by the CEIm of the Hospital Universitario 12 de Octubre.

Written consent will be requested from the participants and / or their relatives / representatives to participate in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Brain Injuries Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pain assessment using a behavioral scale

The pain of the subjects will be evaluated by two independent observers and with a blind result between them, coinciding with the application of two painful procedures used in routine practice: suction of tracheal secretions and the pressure in the nail bed by means of a pressure algometer. In addition, a painless procedure will also be performed to establish an element of control with the procedures painful. This will consist of the application of gentle friction with a cloth gauze, on a part of healthy skin tissue of the patient. The measurement will be performed twice for each patient and procedure depending on the level of sedation, so that the first measurement will be performed with a deeper sedation level and the second with a change in sedation level to moderate-mild.

In turn, the pain assessment will be carried out in three moments: first or baseline measurement, during the application of the painless and 15 minutes after finishing the procedures.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age equal to or greater than 18 years.
2. Inability to communicate verbally or motor.
3. Have a artificial airway.
4. Informed consent of the family member or representative of the patient.

Exclusion Criteria

1. Previous pathology of cognitive impairment.
2. Previous brain injury.
3. Previous psychiatric disorder.
4. Previous dementia.
5. Previous chronic substance abuse.
6. Previous chronic diabetics.
7. Previous spinal cord injury.
8. Previous severe polyneuropathy (diagnosed or suspected).
9. Confirmed diagnosis of brain death.
10. Continuous infusion of muscle relaxants and / or barbiturate coma.
11. Level of deep sedation (RASS -5).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto de Salud Carlos III

OTHER_GOV

Sponsor Role collaborator

Candelas Lopez Lopez

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Candelas Lopez Lopez

RN, MSc, PhD

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Candelas López-López, PhD

Role: STUDY_CHAIR

Emergency and Trauma Intensive Care Unit. Hospital Universitario 12 de Octubre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Emergency and Trauma Intensive Care Unit. Hospital Universitario 12 de Octubre

Madrid, Madrid, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Candelas López-López, PhD

Role: CONTACT

+34 917792634

Santiago Pérez-García, PhD

Role: CONTACT

+34 917792689

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Candelas López-López, PhD

Role: primary

Santiago Pérez-García

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Lopez-Lopez C, Latorre-Marco I, Sanchez-Sanchez MDM, Sarabia-Cobo CM, Solis-Munoz M, Perez-Perez T, Roldan-Merino J, Robleda-Font G. Content Validation of the Behavioural Indicators of Pain Scale in Critically Ill Patients With Acquired Brain Injury: A Delphi Study. Nurs Crit Care. 2025 May;30(3):e70053. doi: 10.1111/nicc.70053.

Reference Type DERIVED
PMID: 40417781 (View on PubMed)

Lopez-Lopez C, Latorre-Marco I, Perez-Perez T, Sarabia-Cobo CM, Solis-Munoz M, Sanchez-Sanchez MDM, Arranz-Esteban A, Frade-Mera MJ, Temprano-Vazquez S, Robleda-Font G. Validity and Reliability of the Behavioural Indicators of Pain Scale Adapted to Patients With Acquired Brain Injury: ESCID-DC Study Protocol. J Adv Nurs. 2025 Aug;81(8):5143-5150. doi: 10.1111/jan.16983. Epub 2025 Apr 18.

Reference Type DERIVED
PMID: 40249752 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ESCID-DC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

3h of PNE on BDNF and Pain Levels
NCT05736172 RECRUITING NA